How glutamine affects bone cell development and bone loss
Metabolic regulation of osteoclast differentiation and bone resorption
['FUNDING_R01'] · UT SOUTHWESTERN MEDICAL CENTER · NIH-11047581
This study is looking at how an important nutrient called glutamine affects bone cells that break down bone, which could help us find new ways to treat bone loss conditions like osteoporosis.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UT SOUTHWESTERN MEDICAL CENTER (nih funded) |
| Locations | 1 site (DALLAS, UNITED STATES) |
| Trial ID | NIH-11047581 on ClinicalTrials.gov |
What this research studies
This research investigates the role of glutamine, an important amino acid, in the development of osteoclasts, which are cells responsible for bone resorption. The study aims to understand how glutamine metabolism influences osteoclast differentiation and bone loss, particularly in conditions like osteoporosis. Researchers will use a mouse model to test the effectiveness of a specific inhibitor on bone resorption and explore the underlying mechanisms of glutamine's effects on these cells. This research could provide insights into new treatments for bone-related diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for osteoporosis or those experiencing significant bone loss.
Not a fit: Patients with conditions unrelated to bone metabolism or those who are not at risk for osteoporosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating osteoporosis and other bone loss conditions.
How similar studies have performed: Previous research has shown promising results in targeting metabolic pathways for bone health, suggesting that this approach could be effective.
Where this research is happening
DALLAS, UNITED STATES
- UT SOUTHWESTERN MEDICAL CENTER — DALLAS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KARNER, COURTNEY MICHAEL — UT SOUTHWESTERN MEDICAL CENTER
- Study coordinator: KARNER, COURTNEY MICHAEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.